The Swiss pharmaceutical company Roche has announced plans to invest $50 billion in the United States over the next five years. This significant financial commitment will support the establishment of cutting-edge research and development sites, along with the creation and expansion of manufacturing facilities across several states, including Indiana, Pennsylvania, Massachusetts, and California.
These developments are projected to generate over 12,000 new jobs. Of these, nearly 6,500 positions will be in construction, while 1,000 jobs will be created at the new and expanded facilities. This initiative reflects Roche’s ongoing dedication to enhancing its research, development, and manufacturing capabilities within the U.S.
By bolstering its infrastructure in the United States, Roche aims to increase its capacity to export medicines from the country, potentially surpassing its import levels. This strategy underscores the company’s longstanding commitment to maintaining a robust global presence, as it operates in more than 130 countries worldwide.